Baker Brothers Advisors - ACHILLION PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$3,943,000
+34.3%
1,095,3590.0%0.03%
+35.0%
Q2 2019$2,936,000
-9.4%
1,095,3590.0%0.02%
-4.8%
Q1 2019$3,242,000
+86.1%
1,095,3590.0%0.02%
+50.0%
Q4 2018$1,742,000
-71.1%
1,095,359
-33.2%
0.01%
-65.0%
Q3 2018$6,035,000
+9.7%
1,639,948
-15.6%
0.04%
-2.4%
Q2 2018$5,500,000
-48.1%
1,943,620
-32.0%
0.04%
-54.4%
Q1 2018$10,598,000
+28.8%
2,856,6370.0%0.09%
+26.8%
Q4 2017$8,227,000
-1.3%
2,856,637
+53.9%
0.07%
+4.4%
Q3 2017$8,336,000
-2.2%
1,856,6370.0%0.07%
-9.3%
Q2 2017$8,522,000
+9.0%
1,856,6370.0%0.08%
+17.2%
Q1 2017$7,816,000
+1.9%
1,856,6370.0%0.06%
-14.7%
Q4 2016$7,668,000
-61.8%
1,856,637
-25.0%
0.08%
-58.8%
Q3 2016$20,052,000
+3.8%
2,475,5150.0%0.18%
-9.9%
Q2 2016$19,309,000
+1.0%
2,475,5150.0%0.20%0.0%
Q1 2016$19,111,000
-11.4%
2,475,515
+23.8%
0.20%
+12.8%
Q4 2015$21,580,000
+56.2%
2,000,0000.0%0.18%
+39.8%
Q3 2015$13,820,000
+2.4%
2,000,000
+31.3%
0.13%
+8.5%
Q2 2015$13,500,000
+539.2%
1,523,739
+611.2%
0.12%
+555.6%
Q1 2015$2,112,000
-60.7%
214,237
-51.1%
0.02%
-67.3%
Q4 2014$5,370,000
+22.7%
438,3370.0%0.06%0.0%
Q3 2014$4,375,000
+31.9%
438,3370.0%0.06%
+34.1%
Q2 2014$3,318,000
+130.1%
438,3370.0%0.04%
+127.8%
Q1 2014$1,442,000
-4.5%
438,337
-3.7%
0.02%
-14.3%
Q4 2013$1,510,000
+9.9%
455,0000.0%0.02%
+5.0%
Q3 2013$1,374,000
-63.1%
455,0000.0%0.02%
-73.0%
Q2 2013$3,722,000455,0000.07%
Other shareholders

There were no reported owners of ACHILLION PHARMACEUTICALS IN in Q3 2023.

NameSharesValueWeighting ↓
View complete list of ACHILLION PHARMACEUTICALS IN shareholders